BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 24178797)

  • 21. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
    Zhuang Z; Vortmeyer AO; Pack S; Huang S; Pham TA; Wang C; Park WS; Agarwal SK; Debelenko LV; Kester M; Guru SC; Manickam P; Olufemi SE; Yu F; Heppner C; Crabtree JS; Skarulis MC; Venzon DJ; Emmert-Buck MR; Spiegel AM; Chandrasekharappa SC; Collins FS; Burns AL; Marx SJ; Lubensky IA
    Cancer Res; 1997 Nov; 57(21):4682-6. PubMed ID: 9354421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
    Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
    [No Abstract]   [Full Text] [Related]  

  • 23. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome.
    Davì MV; Boninsegna L; Dalle Carbonare L; Toaiari M; Capelli P; Scarpa A; Francia G; Falconi M
    Neuroendocrinology; 2011; 94(1):58-65. PubMed ID: 21464564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ; Brouwers AH; van Dullemen HM; van der Jagt EJ; Bongaerts AH; Kema IP; Koopmans KP; Valk GD; Timmers HJ; de Herder WW; Feelders RA; Fockens P; Sluiter WJ; de Vries EG; Links TP
    Gastrointest Endosc; 2015 Jan; 81(1):159-167.e2. PubMed ID: 25527055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype.
    Sala E; Ferrante E; Verrua E; Malchiodi E; Mantovani G; Filopanti M; Ferrero S; Pietrabissa A; Vanoli A; La Rosa S; Zatelli MC; Beck-Peccoz P; Verga U
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):858-62. PubMed ID: 23542451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
    Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
    Tonelli F; Fratini G; Nesi G; Tommasi MS; Batignani G; Falchetti A; Brandi ML
    Ann Surg; 2006 Jul; 244(1):61-70. PubMed ID: 16794390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
    Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
    Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of a nationwide survey of gastrointestinal tumors in Japan].
    Ito T; Tanaka M; Imamura M;
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):128-32. PubMed ID: 18536315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue.
    Mailman MD; Muscarella P; Schirmer WJ; Ellison EC; O'Dorisio TM; Prior TW
    Clin Chem; 1999 Jan; 45(1):29-34. PubMed ID: 9895334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
    Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
    Kornaczewski Jackson ER; Pointon OP; Bohmer R; Burgess JR
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1926-1933. PubMed ID: 28323985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies.
    Pieterman CRC; Hyde SM; Wu SY; Landry JP; Chiang YJ; Christakis I; Grubbs EG; Fisher SB; Graham PH; Waguespack SG; Perrier ND
    Surgery; 2021 Jan; 169(1):175-184. PubMed ID: 32703679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
    Walls GV; Reed AA; Jeyabalan J; Javid M; Hill NR; Harding B; Thakker RV
    Endocrinology; 2012 Nov; 153(11):5167-79. PubMed ID: 23024266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL.
    Moore PS; Missiaglia E; Antonello D; Zamò A; Zamboni G; Corleto V; Falconi M; Scarpa A
    Genes Chromosomes Cancer; 2001 Oct; 32(2):177-81. PubMed ID: 11550286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
    Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.